Biological Evaluation of Medical Devices as an Essential Part of Risk Management Process: Updates and Challenges of ISO 10993-1:2018
In August 2018, a new version of ISO 10993-1 was published, which highlighted the importance of gaining deeper knowledge of the device. In the new version of the standard, not all biological effects should be assessed by biological testing. Some tests can now be waived if there is a sound rationale to support the decision. Read more in our whitepaper.
For more information contact Eurofins Medical Device Testing
E: [email protected]
T: (717) 656-2300
2425 New Holland Pike, Lancaster, PA, 17601, United States